Anna P. Andreou
About
In The Last Decade
Anna P. Andreou
62 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 100
- Psychiatry and Mental health 1.7k
- Pathology and Forensic Medicine 943
- Physiology 744
- Neurology 425
- Endocrine and Autonomic Systems 313
Countries citing papers authored by Anna P. Andreou
This map shows the geographic impact of Anna P. Andreou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna P. Andreou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna P. Andreou more than expected).
Fields of papers citing papers by Anna P. Andreou
This network shows the impact of papers produced by Anna P. Andreou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna P. Andreou. The network helps show where Anna P. Andreou may publish in the future.
Co-authorship network of co-authors of Anna P. Andreou
This figure shows the co-authorship network connecting the top 25 collaborators of Anna P. Andreou. A scholar is included among the top collaborators of Anna P. Andreou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna P. Andreou. Anna P. Andreou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 1 | |
| 3 | 28 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 14 | |
| 7 | 18 | |
| 8 | 18 | |
| 9 | NON-PARALYTIC BOTULINUM MOLECULES FOR THE CONTROL OF MIGRAINE | 2 |
| 10 | 2 | |
| 11 | Non-paralytic botulinum chimeras increase the activation threshold of the trigeminovascular system in migraine models | 3 |
| 12 | 18 | |
| 13 | GABA(A) Receptors in the Nucleus Raphe Magnus Modulate Trigeminal Cell Firing Responsive to Activation of Craniovascular and Dural Afferents | 3 |
| 14 | 91 | |
| 15 | Altered Responses in the Descending Modulatory System of Transgenic Mice with a CACNA1A Mutation | 2 |
| 16 | Transcranial Magnetic Stimulation Inhibits Cortical Spreading Depression but Not Trigeminocervical Activation in Animal Models of Migraine | 3 |
| 17 | Sodium valproate but not gabapentin modulates trigeminovascular nociceptive transmission in the thalamus via GABA(A) receptor mechanisms: implications for migraine | 3 |
| 18 | 37 | |
| 19 | 285 | |
| 20 | CNQX inhibits trigeminovascular neurons in the rat: a microiontophoresis study | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.